Broken String Biosciences appoints Steve Becker as Chief Commercial Officer

FHS
July 24, 2024
10:40 am

Broken String Biosciences (“Broken String”), a genomics company driving development of the next generation of more precise, safe, and effective cell and gene therapies, today announced it has appointed Steve Becker as Chief Commercial Officer.

As Revlimid sales fall, Bristol Myers turns to its next multiple myeloma pill that’s a molecular glue

An experimental pill developed by Bristol Myers Squibb has shown promising efficacy in a clinical trial for advanced multiple myeloma patients who have exhausted most

September 1, 2023

Eckert & Ziegler again achieves sales growth compared to the previous year and confirms its forecast for 2023. Decline in earnings compared to same period last year due to extraordinary items. – Biotech Investments

Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Forecast Eckert & Ziegler again achieves sales growth compared to the previous year and confirms

July 22, 2023

SCAI publishes comprehensive guidelines for STEMI treatment

The Society for Cardiovascular Angiography & Interventions (SCAI) is pleased to announce the publication of the Expert Consensus Statement on the Management of Patients with

October 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.